The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...

Patients with an advanced form of lung cancer lived 56 per cent longer without their disease progressing when radiotherapy was added to the standard of care whole-body therapy, including chemotherapy ...

Experts at The Institute of Cancer Research, London, have hailed findings from a major international trial showing that a personalised cancer vaccine can significantly reduce the risk of melanoma ...

Nearly one third (29.2 per cent) of patients with advanced melanoma saw their tumours disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, ...

Major new research study identifies potential new ways to treat the most common type of bowel cancer, affecting more than 39,000 people in the UK each year. The study, conducted by an international ...

Join us We are recruiting two exceptional Group Leaders to join the Division of Cancer Biology and the Centre for In Vivo Modelling (CIVM). This is a unique opportunity to shape the future of cancer ...

Bladder cancers have variable infiltration of cancer-associated fibroblasts (CAFs). Bladder tumours with more CAFs are associated with worse outcomes after chemotherapy, surgery, immunotherapy and ...

Metastasis, but not the primary tumour, is what leads to the majority of cancer-related deaths, with the liver representing one of the most frequent sites of metastasis for solid tumours 1. Among ...

Paediatric-type diffuse high-grade gliomas (PDHGG) are aggressive childhood brain tumours with devastating prognosis(1). Immunotherapy for these patients is gathering momentum(2). Oncolytic virus (OV) ...